| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | -7,084.556 | -9,992.788 | -7,929.4 | -12,842.914 |
| Net Profit Margin | -121.04 | - | - | - |
| Debt to Asset Ratio | 18.586 | 10.617 | 10.099 | 13.601 |
| Cash Ratio | 935.986 | 839.01 | 1,432.584 | 1,329.352 |
| Quick Ratio | 1,788.374 | 1,550.439 | 1,769.636 | 1,362.563 |
| Current Ratio | 1,788.374 | 1,550.439 | 1,769.636 | 1,362.563 |
Maze Therapeutics, Inc. (MAZE)
Maze Therapeutics, Inc. (MAZE)